Atlas Trials

A Clinical Study of Liposomal Doxorubicin Combined With Ifosfamide Second-line Treatment in Small Cell Lung Cancer

Clinical trial NCT01872416 · UNKNOWN

Trial details

NCT number
NCT01872416
Sponsor
The First Affiliated Hospital of Guangzhou Medical University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Small Cell Lung Cancer
Start date
2012-10-01
Primary completion
2014-05-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.